Cargando…
Nucleotide based covalent inhibitors of KRas can only be efficient in vivo if they bind reversibly with GTP-like affinity
Simple reversible competitive inhibition of nucleotide binding of GTP to Ras family GTPases has long been recognized as an unlikely approach to manipulating the activity of such proteins for experimental or therapeutic purposes. This is due to the high affinity of GTP to GTPases coupled with high ce...
Autores principales: | Müller, Matthias P., Jeganathan, Sadasivam, Heidrich, Angelika, Campos, Jeremy, Goody, Roger S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5473928/ https://www.ncbi.nlm.nih.gov/pubmed/28623374 http://dx.doi.org/10.1038/s41598-017-03973-6 |
Ejemplares similares
-
Targeting oncogenic KRasG13C with nucleotide-based covalent inhibitors
por: Goebel, Lisa, et al.
Publicado: (2023) -
Comprehensive Characterization of (S)GTP-Binding
Proteins by Orthogonal Quantitative (S)GTP-Affinity Profiling and (S)GTP/GTP Competition
Assays
por: Xiao, Yongsheng, et al.
Publicado: (2014) -
Structural impact of GTP binding on downstream KRAS signaling
por: Menyhárd, Dóra K., et al.
Publicado: (2020) -
KRasG12C inhibitors in clinical trials: a short historical perspective
por: Goebel, Lisa, et al.
Publicado: (2020) -
Locking GTPases covalently in their functional states
por: Wiegandt, David, et al.
Publicado: (2015)